GLP-1 Side Effects: What the Whole Class Shares
People usually arrive at this question the same way: they have heard something alarming about one pen and want to know whether it applies to the one they are on. The honest answer is that most of what gets reported belongs to the whole family of medicines rather than to any single brand — which is useful to know, because it means switching brands is often not the fix people hope it is.
Important: PenCompare is an independent comparison platform, not a pharmacy or a prescriber. This page describes the class in general terms and is not a complete list for any product. The patient information leaflet supplied with your pen is the authority for your medicine. If you are unwell right now, contact a healthcare professional rather than reading on.
When to get urgent help
These apply across the class, whichever pen you were prescribed.
Seek urgent medical help — call 999 or go to A&E
- Severe stomach pain that will not go away, especially if it spreads through to your back, with or without vomiting. This can be a sign of pancreatitis
- Signs of a serious allergic reaction: swelling of the face, lips, tongue or throat, difficulty breathing or swallowing, a rapidly spreading rash, or feeling faint
Do not message your online provider and wait for a reply. An online service is not set up to handle an emergency, and the time spent waiting is the thing that causes harm.
Where the line falls
Shared across the class
- The stomach effects — nausea, diarrhoea, vomiting, constipation
- Worst in the first weeks and after each dose increase, then easing
- Pancreatitis and gallbladder problems as the rare but serious ones
- Dehydration when vomiting or diarrhoea goes on too long
Differs between them
- How often each effect is reported, and how the leaflet grades it
- Whether low blood sugar is listed as common or as rare
- How long the unsettled phase lasts, which follows the step-up schedule
- Effects tied to one ingredient rather than to the class
Why the class behaves this way
All of these medicines imitate GLP-1, a hormone the body releases after eating. Among other things, GLP-1 slows the rate at which the stomach empties. That is not a side effect of the mechanism — it is part of the mechanism, and it is much of why appetite drops.
Which explains the pattern. Food sitting in the stomach longer is what produces the nausea, the fullness, the reflux and the constipation. The effects that dominate every leaflet in this class are the same process the treatment depends on, seen from the inside. That is also why they tend to ease: the body adjusts to a rate of emptying it was not used to.
It follows that no pen in this class avoids them by design, and a product advertised as the one without stomach effects is making a claim the mechanism does not support.
Does switching brands help?
Sometimes, and it is a reasonable thing to raise with a prescriber. But it is worth going in with the right expectation, because the shared column above is doing most of the work. Someone who moves from one pen to another to escape nausea is changing the ingredient, not the mechanism, and a fresh step-up phase starts from the beginning either way.
Individual tolerance does vary, and some people genuinely get on better with one than another. What a prescriber will usually try first, though, is holding the current dose longer or stepping it back down — because that addresses the actual cause more directly than a change of brand.
One thing worth saying plainly, since this is a price comparison site: switching because another provider is cheaper is a different decision from switching for clinical reasons, and the two should not be confused. Changing medicine is a prescriber’s call. Changing supplier for the same medicine is yours.
The medicine you are actually on
This page deliberately stays general. For what a specific leaflet lists, how each effect is graded, and the differences that do not carry across the class:
- Mounjaro side effects — tirzepatide, the one that also acts on a second hormone
- Wegovy side effects — semaglutide, including why hair thinning gets reported
- Saxenda side effects — liraglutide, where low blood sugar sits among the common effects rather than the rare ones
Reporting a side effect
Suspected side effects can be reported to the MHRA through the Yellow Card scheme, by you as well as by a healthcare professional. For a class of medicines this widely and recently prescribed, patient reports are a large part of how the picture keeps improving. Deal with being unwell first; report afterwards.
Frequently asked questions
Sources
- Summaries of product characteristics and patient information leaflets for each product, electronic medicines compendium
- NHS 111 — when to use it, and how
- MHRA Yellow Card scheme — reporting a suspected side effect